Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference

Rhea-AI Summary

Castle Biosciences (Nasdaq: CSTL) announced that its executive management will present a company overview at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time. A live audio webcast and subsequent replay will be accessible via the company’s investor relations events webpage.

News Market Reaction – CSTL

+1.22%

+1.22% Session close to close

In the Jul 22 session, CSTL gained 1.22%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Recent insider activity was Net Selling, with 0 shares bought and 13,993 sold during the analyzed pe...

Analysis

Recent insider activity was Net Selling, with 0 shares bought and 13,993 sold during the analyzed period. The announcement provides scheduling information rather than operating results; subsequent disclosures supply the substantive comparison.

Key Figures

Conference edition: 46th annual Presentation date: Aug. 12, 2026 Presentation time: 11:30 a.m. Eastern time

3 metrics

Conference edition 46th annual Canaccord Genuity Growth Conference

Presentation date Aug. 12, 2026 Scheduled conference presentation

Presentation time 11:30 a.m. Eastern time Scheduled conference presentation

Historical Context

5 past events · Latest: Jul 14 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 14	NYSDOH test approval	Positive	+3.9%	NYSDOH approved AdvanceAD-Tx assay for systemic therapy selection in atopic dermatitis patients.
Jul 09	Earnings date announcement	Neutral	+3.9%	Company scheduled second-quarter financial-results release and management webcast for July 30.
Jun 25	Clinical data release	Positive	+6.1%	Prospective DECIDE study showed i31-SLNB outperformed MIA nomogram in melanoma risk prediction.
Jun 23	CFO recognition	Positive	+0.8%	CFO Frank Stokes received recognition among 22 Greater Houston financial leaders.
Jun 16	Order milestone	Positive	-1.0%	TissueCypher surpassed 100,000 clinical orders for Barrett's esophagus risk assessment.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news produced four positive and one negative 24-hour reactions; responses aligned with positive catalysts in three cases.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRIENDSWOOD, Texas, July 22, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 46^th Annual Growth Conference on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time.

A live audio webcast of the Company's presentation will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/ir-events. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com 

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference-302831101.html

SOURCE Castle Biosciences, Inc.

FAQ

When will Castle Biosciences (CSTL) present at the Canaccord Genuity 46th Annual Growth Conference?

Castle Biosciences is scheduled to present on Wednesday, Aug. 12, 2026, at 11:30 a.m. Eastern time. According to Castle Biosciences, executive management will provide a company overview during this session at the Canaccord Genuity 46th Annual Growth Conference.

How can investors listen to Castle Biosciences’ CSTL presentation at the Canaccord Genuity 2026 conference?

Investors can listen via a live audio webcast available on Castle Biosciences’ investor relations events page. According to Castle Biosciences, access is provided through https://ir.castlebiosciences.com/news-events/ir-events at the time of the presentation.

Will there be a replay of Castle Biosciences’ (CSTL) Canaccord Genuity conference presentation?

Yes, a replay of the webcast will be available after the live broadcast concludes. According to Castle Biosciences, investors can access the replay through the same investor relations events section on the company’s website used for the live audio webcast.

What will Castle Biosciences’ management present at the Canaccord Genuity 46th Annual Growth Conference?

Castle Biosciences’ executive management will present a company overview at the conference. According to Castle Biosciences, the session will focus on the company’s business, which centers on innovative diagnostic tests that guide patient care decisions.

Where can I find the link to Castle Biosciences’ (CSTL) conference webcast on August 12, 2026?

The webcast link will be available on Castle Biosciences’ investor relations news and events page. According to Castle Biosciences, investors should visit https://ir.castlebiosciences.com/news-events/ir-events to access both the live audio webcast and the replay.